The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of survival with tumor antigen expression in patients with newly diagnosed glioblastoma receiving a multi-epitope pulsed dendritic cell vaccine.
Surasak Phuphanich
Research Funding - ImmunoCellular Therapeutics
Christopher Jay Wheeler
No relevant relationships to disclose
Jeremy Rudnick
No relevant relationships to disclose
Mia Mazer
No relevant relationships to disclose
Hong Qiang Wang
No relevant relationships to disclose
Miriam Nuno
No relevant relationships to disclose
Jaime Richardson
No relevant relationships to disclose
Xuemo Fan
No relevant relationships to disclose
Jianfei Ji
No relevant relationships to disclose
Ray M Chu
No relevant relationships to disclose
James Bender
Employment or Leadership Position - ImmuneCellular Therapeutics
Elma S. Hawkins
Consultant or Advisory Role - ImmunoCellular Therapeutics
Stock Ownership - ImmuneCellular Therapeutics
Chirag Patil
No relevant relationships to disclose
Keith L. Black
Consultant or Advisory Role - ImmuneCellular Therapeutics
Stock Ownership - ImmuneCellular Therapeutics
John Yu
Employment or Leadership Position - ImmunoCellular Therapeutics
Stock Ownership - ImmunoCellular Therapeutics